Skip to main content

Advertisement

Table 2 Anticancer activities of Zingiber officinale extracts against MCF-7 and MDA-MB-231 cell lines (determined by the MTT assay at concentration 37.5 μg/ml)

From: RETRACTED ARTICLE: In vitro antioxidant and anticancer activity of young Zingiber officinale against human breast carcinoma cell lines

CO2 (μmol/mol) Varieties Parts MCF-7 MDA-MB-231
  Fulbaria Aerial parts Rhizomes 59.65 ± 2.55b 57.56 ± 1.68b 63.31 ± 1.85e 69.41 ± 2.30b
400     
  Syedpuri Aerial parts Rhizomes 50.65 ± 0.56e 56.98 ± 1.74b 58.12 ± 1.09a 66.61 ± 2.31b,e
  Fulbaria Aerial parts Rhizomes 40.37 ± 1.46c 48.97 ± 1.04e 48.16 ± 1.03c 44.35 ± 1.86d
800     
  Syedpuri Aerial parts Rhizomes 44.93 ± 1.53a 39.01 ± 2.1c 43.02 ± 1.99d 40.16 ± 2.42f
Positive control Tamoxifen 24.9 ± 1.6 26.70 ± 2.11
  1. All analyses are the mean of triplicate measurements ± standard deviation. Means not sharing a common letter were significantly different at P ≤ 0.05.
  2. Results expressed in percent of cell viability.